MPWM Advisory Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$164K Buy
6,824
+286
+4% +$7.48K 0.08% 118
2026
Q1
$184K Sell
6,538
-12
-0.2% -$319 0.1% 107
2025
Q4
$163K Buy
6,550
+1,821
+39% +$45.9K 0.09% 101
2025
Q3
$121K Sell
4,729
-1,570
-25% -$38.8K 0.07% 106
2025
Q2
$153K Sell
6,299
-347
-5% -$8.09K 0.1% 93
2025
Q1
$168K Buy
6,646
+825
+14% +$21.6K 0.12% 74
2024
Q4
$154K Buy
+5,821
New +$158K 0.11% 82

Other funds holding PFE

MPWM Advisory Solutions's PFE Position: Q2 2026 in Review

MPWM Advisory Solutions increased its Pfizer (PFE) stake by 4.4% in Q2 2026, buying an estimated $7.48K and bringing the position to 6,824 shares worth $164K. The position accounts for 0.08% of the portfolio, ranked #118.

MPWM Advisory Solutions first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $184K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • MPWM Advisory Solutions held 6,824 shares of Pfizer worth $164K as of Q2 2026.
  • MPWM Advisory Solutions bought 286 Pfizer shares in Q2 2026, an estimated $7.48K.
  • Pfizer made up 0.08% of MPWM Advisory Solutions's portfolio in Q2 2026, its #118 holding.
  • MPWM Advisory Solutions first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • MPWM Advisory Solutions's Pfizer position peaked at $184K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MPWM Advisory Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.